3.11
price up icon5.07%   0.15
after-market After Hours: 3.01 -0.10 -3.22%
loading
Voyager Therapeutics Inc stock is traded at $3.11, with a volume of 990.18K. It is up +5.07% in the last 24 hours and up +13.50% over the past month. Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
See More
Previous Close:
$2.96
Open:
$2.96
24h Volume:
990.18K
Relative Volume:
2.01
Market Cap:
$191.46M
Revenue:
$163.78M
Net Income/Loss:
$25.88M
P/E Ratio:
4.7846
EPS:
0.65
Net Cash Flow:
$-28.66M
1W Performance:
+5.78%
1M Performance:
+13.50%
6M Performance:
-45.15%
1Y Performance:
-60.68%
1-Day Range:
Value
$2.935
$3.17
1-Week Range:
Value
$2.83
$3.17
52-Week Range:
Value
$2.645
$9.55

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Name
Name
Voyager Therapeutics Inc
Name
Phone
857-259-5340
Name
Address
75 HAYDEN AVENUE, LEXINGTON, MA
Name
Employee
172
Name
Twitter
@VoyagerTx
Name
Next Earnings Date
2025-03-11
Name
Latest SEC Filings
Name
VYGR's Discussions on Twitter

Compare VYGR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VYGR
Voyager Therapeutics Inc
3.11 191.46M 163.78M 25.88M -28.66M 0.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.20 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
525.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.09 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
551.22 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.07 28.51B 3.81B -644.79M -669.77M -6.24

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-10-25 Initiated Cantor Fitzgerald Overweight
Dec-02-24 Initiated Citigroup Buy
Nov-29-24 Resumed Wedbush Outperform
Oct-16-24 Initiated Leerink Partners Outperform
Mar-26-24 Initiated Guggenheim Buy
Mar-19-24 Initiated H.C. Wainwright Buy
Mar-07-24 Initiated Citigroup Buy
Jan-02-24 Upgrade Wells Fargo Equal Weight → Overweight
May-10-23 Initiated Truist Buy
Mar-10-23 Initiated Oppenheimer Outperform
Oct-07-21 Upgrade Robert W. Baird Neutral → Outperform
Feb-26-21 Downgrade Robert W. Baird Outperform → Neutral
Feb-03-21 Downgrade BTIG Research Buy → Neutral
Feb-03-21 Downgrade Wedbush Outperform → Neutral
Dec-24-20 Downgrade Cantor Fitzgerald Overweight → Neutral
Dec-23-20 Downgrade Raymond James Outperform → Mkt Perform
Nov-11-20 Downgrade Oppenheimer Outperform → Perform
Nov-10-20 Downgrade Raymond James Strong Buy → Outperform
Nov-10-20 Downgrade Wells Fargo Overweight → Equal Weight
Mar-19-20 Initiated The Benchmark Company Buy
Feb-06-20 Initiated Oppenheimer Outperform
Nov-15-18 Upgrade Raymond James Outperform → Strong Buy
Sep-10-18 Resumed BTIG Research Buy
Sep-10-18 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-04-18 Initiated H.C. Wainwright Buy
Mar-12-18 Downgrade Evercore ISI Outperform → In-line
Mar-12-18 Downgrade Wedbush Outperform → Neutral
Feb-02-18 Initiated Morgan Stanley Overweight
Nov-28-17 Resumed Piper Jaffray Overweight
Oct-31-17 Initiated Robert W. Baird Outperform
Oct-27-17 Initiated Canaccord Genuity Buy
Oct-23-17 Reiterated Stifel Buy
Oct-12-17 Initiated Raymond James Outperform
Aug-17-17 Initiated Evercore ISI Outperform
Jul-28-17 Resumed Stifel Buy
View All

Voyager Therapeutics Inc Stock (VYGR) Latest News

pulisher
Jun 18, 2025

Financial Comparison: Prime Medicine (NYSE:PRME) & Voyager Therapeutics (NASDAQ:VYGR) - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Voyager Therapeutics at H.C. Wainwright: Genetic Innovation in Focus By Investing.com - Investing.com Canada

Jun 17, 2025
pulisher
Jun 11, 2025

Equities Analysts Offer Predictions for VYGR FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspecti - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference | VYGR Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewswire

Jun 10, 2025
pulisher
Jun 09, 2025

Millennium Management LLC Sells 60,935 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Decreases Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade) - Seeking Alpha

Jun 06, 2025
pulisher
Jun 05, 2025

Voyager Therapeutics Approves Stock Plans at Annual Meeting - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Sells 43,210 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Holdings Lowered by ProShare Advisors LLC - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Cuts Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Jun 01, 2025
pulisher
May 31, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Jane Street Group LLC - Defense World

May 31, 2025
pulisher
May 31, 2025

Voyager Therapeutics stock plunges to 52-week low of $2.71 By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 31, 2025

Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 31, 2025
pulisher
May 30, 2025

Voyager Therapeutics stock plunges to 52-week low of $2.71 - Investing.com

May 30, 2025
pulisher
May 27, 2025

It's Unlikely That The CEO Of Voyager Therapeutics, Inc. (NASDAQ:VYGR) Will See A Huge Pay Rise This Year - simplywall.st

May 27, 2025
pulisher
May 26, 2025

Northern Trust Corp Raises Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

May 26, 2025
pulisher
May 20, 2025

With 46% ownership, Voyager Therapeutics, Inc. (NASDAQ:VYGR) has piqued the interest of institutional investors - Yahoo Finance

May 20, 2025
pulisher
May 20, 2025

Cubist Systematic Strategies LLC Buys New Shares in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

May 20, 2025
pulisher
May 16, 2025

Tower Research Capital LLC TRC Increases Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

May 16, 2025
pulisher
May 16, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Brokerages - Defense World

May 16, 2025
pulisher
May 15, 2025

Voyager Therapeutics (VYGR) Showcases Breakthrough in Gene Thera - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Revolutionary Brain Drug Delivery: Voyager's New Gene Therapy Shows 400x Improvement in Landmark Research - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Voyager reports breakthrough in brain drug delivery - Investing.com

May 15, 2025
pulisher
May 13, 2025

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Voyager Therapeutics (VYGR) and Privia Health Group (PRVA) - The Globe and Mail

May 13, 2025
pulisher
May 12, 2025

Q2 EPS Forecast for Voyager Therapeutics Reduced by Analyst - Defense World

May 12, 2025
pulisher
May 12, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock Position Increased by Dimensional Fund Advisors LP - Defense World

May 12, 2025
pulisher
May 11, 2025

FY2025 EPS Estimates for VYGR Increased by Cantor Fitzgerald - Defense World

May 11, 2025
pulisher
May 10, 2025

Leerink Partnrs Has Negative Outlook of VYGR Q2 Earnings - Defense World

May 10, 2025
pulisher
May 10, 2025

Q2 EPS Estimates for Voyager Therapeutics Lifted by Wedbush - Defense World

May 10, 2025
pulisher
May 08, 2025

Voyager Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 08, 2025
pulisher
May 08, 2025

Barclays PLC Buys 10,328 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

May 08, 2025
pulisher
May 08, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Omnicell (OMCL), Voyager Therapeutics (VYGR) and Masimo (MASI) - The Globe and Mail

May 08, 2025
pulisher
May 07, 2025

Voyager Therapeutics Inc earnings missed by $0.08, revenue fell short of estimates - Investing.com India

May 07, 2025
pulisher
May 07, 2025

Raymond James Financial Inc. Takes $746,000 Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

May 07, 2025
pulisher
May 06, 2025

Voyager Therapeutics: Q1 Earnings Snapshot - Connecticut Post

May 06, 2025
pulisher
May 06, 2025

Voyager Reports First Quarter 2025 Financial and Operating Results - The Manila Times

May 06, 2025
pulisher
May 06, 2025

Voyager Therapeutics Q1 2025 Financial and Operating Results - TradingView

May 06, 2025
pulisher
May 06, 2025

Voyager Therapeutics, Inc. SEC 10-Q Report - TradingView

May 06, 2025
pulisher
May 02, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Renaissance Technologies LLC - Defense World

May 02, 2025
pulisher
May 01, 2025

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer - Stock Titan

May 01, 2025
pulisher
May 01, 2025

BlackRock, Inc. Reduces Stake in Voyager Therapeutics Inc - GuruFocus

May 01, 2025

Voyager Therapeutics Inc Stock (VYGR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Voyager Therapeutics Inc Stock (VYGR) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Sandrock Alfred
President and CEO
Apr 02 '25
Sale
3.43
10,885
37,336
430,931
$20.66
price up icon 0.78%
$36.03
price up icon 0.45%
$21.28
price up icon 3.30%
$100.64
price up icon 1.16%
$106.47
price down icon 0.23%
biotechnology ONC
$242.07
price up icon 0.36%
Cap:     |  Volume (24h):